2006
DOI: 10.1007/s11095-006-9120-4
|View full text |Cite
|
Sign up to set email alerts
|

A Modern View of Excipient Effects on Bioequivalence: Case Study of Sorbitol

Abstract: As exemplified by sorbitol, some common excipients have unexpected effect on bioavailability/bioequivalence, depending on the pharmacokinetic characteristics of the drug, as well as the type and amount of the excipient present in the formulation. More research is warranted to examine other 'common' excipients that may have unintended influence on bioavailability/bioequivalence.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

3
53
0
1

Year Published

2008
2008
2023
2023

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 73 publications
(57 citation statements)
references
References 58 publications
(35 reference statements)
3
53
0
1
Order By: Relevance
“…Sorbitol had the greatest impact on lamivudine C max and AUC 0‐24 , and delayed t max , which suggests that sorbitol's effect was primarily on the absorption and bioavailability of lamivudine. These findings are consistent with the observed dose‐dependent effects of sugar alcohols on GI transit time and the PK parameters of low permeable drugs such as ranitidine and cimetidine 10, 14. For example, ranitidine t max was delayed, and a linear relationship was noted between the dose of sorbitol and ranitidine bioavailability, with 7.2%, 25%, and 45.5% reduction in ranitidine AUC, respectively, as the amount of sorbitol was increased from 1.25 to 2.5 to 5 g 10.…”
Section: Discussionsupporting
confidence: 89%
See 3 more Smart Citations
“…Sorbitol had the greatest impact on lamivudine C max and AUC 0‐24 , and delayed t max , which suggests that sorbitol's effect was primarily on the absorption and bioavailability of lamivudine. These findings are consistent with the observed dose‐dependent effects of sugar alcohols on GI transit time and the PK parameters of low permeable drugs such as ranitidine and cimetidine 10, 14. For example, ranitidine t max was delayed, and a linear relationship was noted between the dose of sorbitol and ranitidine bioavailability, with 7.2%, 25%, and 45.5% reduction in ranitidine AUC, respectively, as the amount of sorbitol was increased from 1.25 to 2.5 to 5 g 10.…”
Section: Discussionsupporting
confidence: 89%
“…These findings are consistent with the observed dose‐dependent effects of sugar alcohols on GI transit time and the PK parameters of low permeable drugs such as ranitidine and cimetidine 10, 14. For example, ranitidine t max was delayed, and a linear relationship was noted between the dose of sorbitol and ranitidine bioavailability, with 7.2%, 25%, and 45.5% reduction in ranitidine AUC, respectively, as the amount of sorbitol was increased from 1.25 to 2.5 to 5 g 10. Sorbitol (5 g) had less effect on the higher permeability drugs metoprolol (17% reduction in bioavailability) and theophylline (no effect).…”
Section: Discussionsupporting
confidence: 89%
See 2 more Smart Citations
“…Clinical considerations may weigh against the use of nutritive sweeteners due to their cariogenic potential and comorbidity issues (e.g., diabetes). In addition, some nonabsorbable sweeteners (e.g., sugar alcohols) may increase intestinal motility and thus may adversely affect the absorption of some medications or cause diarrhea (29).…”
Section: Palatability and Taste Maskingmentioning
confidence: 99%